Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study.

Respir Res · 2023 · PMC10521462 · PMID 37749551

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

Time-to-first subsequent exacerbation did not differ significantly according to the timing of treatment initiation, though a slight trend towards longer median time-to-first moderate exacerbation could be observed among prompt vs. delayed initiators (Fig. 4 ).

also in 1,639 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.